WHO ICTRP trial
BALLAD BELGIUM: A trial to evaluate the potential benefit of adjuvant…
EUCTR2018-002831-65-BE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-002831-65-BE |
|---|---|
| Public title | BALLAD BELGIUM: A trial to evaluate the potential benefit of adjuvant chemotherapy, that means a chemotherapy in addition to the curative surgery for small bowel adenocarcinoma |
| Scientific title | BALLAD BELGIUM: A trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma |
| Primary sponsor | Belgian Group of Digestive Oncology (BGDO) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Belgium |
| Conditions | small bowel adenocarcinoma;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Fluorouracil Accord Healthcare 50 mg/ml, solution pour injection ou perfusion Pharmaceutical Form: Solution for infusion INN or Proposed INN: FLUOROURACIL 50 mg /ml Other descriptive name: FLUOROURACIL Concentration number: 50… |
| Registration date | Oct 24, 2018 |
| Target size | 30 |
| Secondary IDs | 21121214 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: